Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
about
Receptor tyrosine kinase-mediated angiogenesisA novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like diseaseThe Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vesselBrn3a regulates the transition from neurogenesis to terminal differentiation and represses non-neural gene expression in the trigeminal ganglionBlood vessels as targets in tumor therapyElevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin TumorsShort and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice.Tumour vascularization: sprouting angiogenesis and beyondThe VEGF family in cancer and antibody-based strategies for their inhibition.Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc-dependent transcripts in human lung fibroblastsLymphangiogenesis and lymphatic metastasis in breast cancer.The lymphatic system in health and disease.Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancerLymphatics in lung disease.VEGF signaling has distinct spatiotemporal roles during heart valve development.Existence of the lymphatic system in the primate corpus luteum.Blood and lymphatic vasculature in the ovary: development, function and disease.The biophysical property of A549 cells transferred by VEGF-D.Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.Tumor lymphangiogenesis as a potential therapeutic target.Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancerRadiogenic lymphangiogenesis in the skinLymphangiogenesis and cancerComparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorptionMolecular regulation of lymphangiogenesis in development and tumor microenvironment.Localization of C-Fos-Induced Growth Factor (Figf) mRNA Expression in the Mouse Uterus during Implantation.The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryosPotential therapeutic strategies for lymphatic metastasis.Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.Aberrant pulmonary lymphatic development in the nitrofen mouse model of congenital diaphragmatic hernia.A (selective) history of Australian involvement in cytokine biology.Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis.
P2860
Q27001612-D69FF6F8-230A-4502-AAD2-BA7B008D7A0EQ28238461-ACD50C5C-B6FF-4684-94C0-ADAA4C23FF2CQ28244709-0D5F4A4A-FAF7-4345-B9D5-B961031895A3Q28509777-9F0B6FBC-4011-4D81-BEC4-9F721A08E3A0Q28590737-6C7FC532-6980-4A21-9A65-85E54F1E5CD7Q28829519-46C1232E-4EA4-4081-9EF4-27E1072DA0AEQ33267276-92F771B0-8CF1-41DD-8601-4DCFA90A82E7Q33556162-F298326C-D57A-4B1D-8034-8A297AAA8CC3Q33733437-03CBA87E-6261-44DD-AB4C-74F49BE9C295Q33881566-FD596A60-BCD2-47AD-82DA-6ACC8895551EQ33940058-C5AAD764-1E73-4838-9111-255C0700CC73Q34015299-378BE940-B11D-4E5F-908D-A3987338E554Q34016911-D14FC491-CB6A-4C51-8195-92F2B159850DQ34160672-7E41CCA9-3776-42CF-A61F-07A759B80368Q34216642-F76934C1-FC32-4042-BA12-59B62565089CQ34347218-10DA85BA-23A3-41E8-89AC-EA807C091457Q34375633-36853E74-6C4E-419C-AA19-1769CCC11313Q34633821-C8365D11-2EC3-4A5E-82B9-AC1D00BD088AQ35374781-5A88026C-B95D-4037-B654-25CA39AF11F7Q35574091-1816B60B-6D09-4923-9215-31CE8AF61A74Q35682284-8F30B6C2-D215-462C-839C-A0BB72D712A0Q35691635-509E108C-8435-4F35-B425-6031DB22D5A5Q35695806-9383860F-BAB9-446C-90BA-1CEEAFB2E627Q35838122-B0400C9E-1E90-4496-99C5-7A279C161E61Q35895234-A33CCAF2-5BE4-4157-BB43-0FACC8E0320EQ35913687-64DBC28F-0F36-4640-BF9C-344F3C3D3B81Q35928217-B9DF1588-61E0-4C3E-B490-3E57285685C5Q36137692-BA7CB6FD-FF78-45FD-8988-C0B0B48B2066Q36138509-B279933A-012C-4C8B-B6FC-A18B58DF9D66Q36278721-9BF95EE7-97A2-47DF-84F6-B8920E7C974CQ36284953-763CAA21-5043-4763-B82E-CC3B773FE261Q36608614-4A39A8B0-F4CE-48F7-8754-77C397C462AAQ36708521-75657876-9013-4176-BA90-FE40E14B8DBBQ36804671-141F61B8-F417-4E89-83C7-075016A1D82EQ36851512-3622025F-6CC2-4F10-97A3-EC0552301CBFQ36951786-D9FA44EC-40D2-4822-AC83-E1AFF0902C1CQ37009369-52EAFD3E-E243-4B47-8F04-49BF995877B5Q37018307-B31DCB71-D190-4F60-9AF7-2CFAEFED711FQ37109977-00C04DFC-4CAB-4A4A-B22C-6EA81C9527B5Q37341131-BA23E9A1-AE5F-45F5-99B2-8A57CFF609C1
P2860
Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Vascular endothelial growth fa ...... opment of the lymphatic system
@nl
Vascular endothelial growth fa ...... pment of the lymphatic system.
@ast
Vascular endothelial growth fa ...... pment of the lymphatic system.
@en
type
label
Vascular endothelial growth fa ...... opment of the lymphatic system
@nl
Vascular endothelial growth fa ...... pment of the lymphatic system.
@ast
Vascular endothelial growth fa ...... pment of the lymphatic system.
@en
prefLabel
Vascular endothelial growth fa ...... opment of the lymphatic system
@nl
Vascular endothelial growth fa ...... pment of the lymphatic system.
@ast
Vascular endothelial growth fa ...... pment of the lymphatic system.
@en
P2093
P2860
P3181
P1476
Vascular endothelial growth fa ...... pment of the lymphatic system.
@en
P2093
Dianne Grail
Hajime Kubo
Margaret L Hibbs
Megan E Baldwin
Michael M Halford
Richard A Williams
Sally Roufail
P2860
P304
P3181
P356
10.1128/MCB.25.6.2441-2449.2005
P407
P577
2005-03-01T00:00:00Z